4-[(5-cyclopropyl-1,2,4-oxadiazol-3-yl)methyl]-6-methyl-3-oxo-N-[(pyridin-2-yl)methyl]-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamide
Chemical Structure Depiction of
4-[(5-cyclopropyl-1,2,4-oxadiazol-3-yl)methyl]-6-methyl-3-oxo-N-[(pyridin-2-yl)methyl]-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamide
4-[(5-cyclopropyl-1,2,4-oxadiazol-3-yl)methyl]-6-methyl-3-oxo-N-[(pyridin-2-yl)methyl]-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamide
Compound characteristics
| Compound ID: | L310-2769 |
| Compound Name: | 4-[(5-cyclopropyl-1,2,4-oxadiazol-3-yl)methyl]-6-methyl-3-oxo-N-[(pyridin-2-yl)methyl]-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamide |
| Molecular Weight: | 455.49 |
| Molecular Formula: | C21 H21 N5 O5 S |
| Smiles: | Cc1cc2c(cc1S(NCc1ccccn1)(=O)=O)OCC(N2Cc1nc(C2CC2)on1)=O |
| Stereo: | ACHIRAL |
| logP: | 2.1727 |
| logD: | 2.1655 |
| logSw: | -2.7757 |
| Hydrogen bond acceptors count: | 12 |
| Hydrogen bond donors count: | 1 |
| Polar surface area: | 108.561 |
| InChI Key: | RCQUTYXBWXABEZ-UHFFFAOYSA-N |